Cargando…
TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2
Antiviral therapeutics are a front-line defense against virally induced diseases. Because viruses frequently mutate to escape direct inhibition of viral proteins, there is interest in targeting the host proteins that the virus must co-opt to complete its replication cycle. However, a detailed unders...
Autores principales: | Trimarco, Joseph D., Heaton, Brook E., Chaparian, Ryan R., Burke, Kaitlyn N., Binder, Raquel A., Gray, Gregory C., Smith, Clare M., Menachery, Vineet D., Heaton, Nicholas S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189496/ https://www.ncbi.nlm.nih.gov/pubmed/34043740 http://dx.doi.org/10.1371/journal.ppat.1009599 |
Ejemplares similares
-
Genome-scale CRISPR screen identifies TMEM41B as a multi-function host factor required for coronavirus replication
por: Sun, Limeng, et al.
Publicado: (2021) -
A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice
por: Chaparian, Ryan R., et al.
Publicado: (2022) -
Influenza A virus segments five and six can harbor artificial introns allowing expanded coding capacity
por: Froggatt, Heather M., et al.
Publicado: (2021) -
Cellular glycan modification by B3GAT1 broadly restricts influenza virus infection
por: Trimarco, Joseph D., et al.
Publicado: (2022) -
VMP1 and TMEM41B are essential for DMV formation during β-coronavirus infection
por: Ji, Mingming, et al.
Publicado: (2022)